Dennery PA, Seidman DS, Stevenson DK (2001). Neonatal hyperbilirubinaemia. New Engl. J. Med. 344:581-590.
Crossref

Edwards MS (2002). Postnatal Bacterial Infections. In: Fanaroff, A. A., Martin R. J (eds). Neonatal Perinatal Medicine: Diseases of the foetus and infant, 7thed, St. Louis, C. V. Mosby. pp. 706-726.

Egesie OJ, Joseph EE, Isiguzozo I, Egesie UG (2008). Glucose 6 – Phosphatedehydrogenase (G6PD) activity and deficiency in a population of Nigerian males resident in Jos. Niger. J. Physiol. Sci. 23(1-2):9-11.

Egube BA, Ofili AN, Isara AR, Onakewhor JU (2013). Neonatal jaundice and its management: Knowledge, attitude and practice among expectant mothers attending antenatal clinic at University of Benin Teaching Hospital, Benin City. Niger. J. Clin. Pract. 16:188-194.
Crossref

Ezechukwu CC, Ugochukwu EF, Egbuonu I, Chukwuka JO (2004). Risk factors from neonatal mortality in regional tertiary hospital in Nigeria. Niger. J. Clin. Pract. 7:50-52.

George IO, Akani NA (2011). Evaluation of Glucose – 6 – Phosphate dehydrogenase deficiency in icteric newborns in Nigeria. Am. J. Trop. Med. Public Health 1(3):73-78.

Hamid MH, Chisti AL, Mumtaz A, Hussain S, Maqbool S (2003). Bilirubin estimation in neonatal jaundice. A comparative study between auto analyzer (Diazo Method) and bilicubinometer (direct photometric method). Pak. Paediatr. J. 27:68-73.

Iacob D, Boia M, Iacob RE, Manae A (2011). Neonatal Jaundice – Etiology and Incidence. Jurnalul Pediatrului 14(55-56).

Kavehmanesh Z, Mohammadieh NE, Zarchi AAK, Amirsalari S, Matinzadeh ZK, Torkaman M (2008). Prevalence of readmission for hyperbilirubinaemia in healthy newborns. Iran. J. Pediatr. 18(2):130-136.

Lawn JE, Cousens S, Zupan J (2005). Four million neonatal deaths: When? Where? Why? Lancet 365:891-900.
Crossref

Maisels MJ, Kring E (1998). Length of stay, jaundice and hospital admission. Pediatrics 101(6):995-998.
Crossref

Najib KS, Saki F, Hemmati F, Inaloo S (2013) Risk factors and causes of severe neonatal hyperbilirubinemia in the South of Iran (Fars Province). Iran Red Cross Med. J. 15(3):260 -263.
Crossref

Newman TB, Liljestrand P, Jeremy RJ (2006). Outcomes among newborns with total serum bilirubin levels of 25mg per deciliter or more. New Engl. J. Med. 354:1889-1900.
Crossref

Oladokun A, Otegbayo JA, Adeniyi AA (2009). Maternal and foetaloutcomes of jaundice in pregnancy at the University College Hospital, Ibadan. Nigerian J. Clin. Pract. 12(3):277-280.

Onyearugha CN, Onyire BN, Ugboma HAA (2011). Neonatal jaundice: Prevalence and Associated factors as seen in Federal Medical Centre Abakaliki, Southeast Nigeria. J. Clin. Med. Res. 3(3):40-45.

Porter ML, Dennis BL (2002). Hyperbilirubinemia in the term newborn. Am. Family Phys. 65(4):599-607.

Sciuto M, Bertino G, Zocco M, Vecchio I, Raffaele R, Trifiletti, R, Pavone P (2009). Incidence and causes of neonatal hyperbilirubinemia in a center of Catania.Therapeut. Clin. Risk Manage. 5:247-250.

Slusher TM, Angyo IA, Bode-Thomas F, McLaren DW, Wong RJ (2004). Transcutaneous bilirubin measurements and serum total bilirubin levels in indigenous African infants. Pediatrics 113(6):1636-1641.
Crossref

Tikmani SS, Warraich HJ, Abbasi F, Rizvi A, Darmstadt FL, Zaidi AKM (2010). Incidence of Neonatal hyperbilirubinemia: a population – based prospective Study in Pakistan. Trop. Med. Int. Health 15(5):502 -507.
Crossref

Udo JJ, Anah MU, Ochigbo SO, Etuk IS, Ekanem AD (2008). Neonatal morbidity and mortality in Calabar Nigeria: A hospital based study. Nigerian J. Clin. Pract. 11(3):285-289.

Wang M, Hays T, Ambruso DR, Silliman CC, Dickey WC (2005). Haemolytic disease of the newborn caused by a high titer anti-Group B IgG from a Group A mother. Pediatr. Blood Cancer 45(6):861-862.
Crossref

West BA, Tabansi PN (2014). The prevalence of neonatal septicaemia in the University of PortHarcourt Teaching Hospital, Nigeria. J. Paediatr. 41(1):33-37.